(Q40122262)

17 September 2017

1 reference

title

The renin system and future trends in management of high blood pressure (English)

1 reference

17 September 2017

The Renin System and Future Trends in Management of High Blood Pressure (English)

1 reference

https://api.crossref.org/works/10.3109/10641968009037128

7 September 2023

author name string

J. H. Laragh

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6253242

7 September 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6253242

7 September 2023

publication date

1 January 1980

1 reference

full work available at URL

17 September 2017

http://www.tandfonline.com/doi/pdf/10.3109/10641968009037128

1 reference

https://api.crossref.org/works/10.3109/10641968009037128

Clinical and Experimental Hypertension

7 September 2023

published in

1 reference

17 September 2017

volume

2

1 reference

17 September 2017

issue

3-4

1 reference

17 September 2017

page(s)

525-552

1 reference

PROLONGED INFUSIONS OF ANGIOTENSIN II AND NOREPINEPHRINE AND BLOOD PRESSURE, ELECTROLYTE BALANCE, AND ALDOSTERONE AND CORTISOL SECRETION IN NORMAL MAN AND IN CIRRHOSIS WITH ASCITES.

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037128

Plasma renin and "prorenin" in essential hypertension during sodium depletion, beta-blockade, and reduced arterial pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037128

Essential hypertension: renin and aldosterone, heart attack and stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037128

Antihypertensive beta blocking action as related to renin and age: A pharmacologic tool to identify pathogenetic mechanisms in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037128

Possible Role of Renin in Hypertension as Suggested by Renin-Sodium Profiling and Inhibition of Converting Enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037128

Unexpected pressor responses to propranolol in essential hypertension. An interaction between renin, aldosterone and sympathetic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037128

An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037128

Aldosterone secretion and primary and malignant hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037128

Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037128

Modern system for treating high blood pressure based on renin profiling and vasoconstriction-volume analysis: A primary role for beta blocking drugs such as propranolol

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037128

Renin Profiling for Diagnosis and Treatment of Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037128

Use of an Angiotensin II Antagonist (Saralasin) in the Recognition of “Angiotensinogenic” Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10641968009037128

The New England Journal of Medicine

21 January 2018

1

284

Amery A.

1976

1 reference

https://api.crossref.org/works/10.3109/10641968009037128

Further studies with propranolol in psychotic patients. Relation to initial psychiatric state, urinary catecholamines and 3-methoxy-4-hydroxyphenylglycol excretion

7 September 2023

4

1 reference

https://api.crossref.org/works/10.3109/10641968009037128

Detection of renovascular hypertension with angiotensin II blockade

7 September 2023

5

1 reference

https://api.crossref.org/works/10.3109/10641968009037128

Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure

7 September 2023

7

1 reference

https://api.crossref.org/works/10.3109/10641968009037128

Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases

7 September 2023

8

1 reference

https://api.crossref.org/works/10.3109/10641968009037128

Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients

7 September 2023

10

1 reference

https://api.crossref.org/works/10.3109/10641968009037128

THE ROLE OF BLOOD-PRESSURE CONTROL IN PREVENTING COMPLICATIONS OF HYPERTENSION

7 September 2023

17

1 reference

https://api.crossref.org/works/10.3109/10641968009037128

Unexpected agonistic pressor effect of propranolol and angiotensin II in bilaterally nephrectomized rats

7 September 2023

19

1 reference

https://api.crossref.org/works/10.3109/10641968009037128

A role for renin in rebound hypertension and encephalopathy after infusion of saralasin acetate (Sar1-Ala8-angiotensin II)

7 September 2023

20

1 reference

https://api.crossref.org/works/10.3109/10641968009037128

Hypotensive agents and pressor substances. The effect of epinephrine, norepinephrine, angiotensin II, and others on the secretory rate of aldosterone in man

7 September 2023

22

1 reference

https://api.crossref.org/works/10.3109/10641968009037128

Renin as a predictor of hypertensive complications: discussion

7 September 2023

28

1 reference

https://api.crossref.org/works/10.3109/10641968009037128

Angiotensin II blockade in patients with essential hypertension

7 September 2023

31

1 reference

https://api.crossref.org/works/10.3109/10641968009037128

Renin, sodium, and vasodepressor response to saralasin in renovascular and essential hypertension

7 September 2023

32

1 reference

https://api.crossref.org/works/10.3109/10641968009037128

Beta adrenergic blockade in hypertension. Practical and theoretical implications of long-term hemodynamic variations

7 September 2023

37

1 reference

https://api.crossref.org/works/10.3109/10641968009037128

7 September 2023

Identifiers

1 reference

17 September 2017

1 reference